PMTAs: after the Reynolds approvals, which way will the FDA go next?

The FDA’s first premarket approval for a vapour product that has gone through the premarket tobacco product applications (PMTAs) process shows that it is not opposed to all vaping products, although it is also significant that it refused approval for all non-tobacco flavours (although menthol is still under review). Tobacco organisations praised the decision but said it needs to go further in future. Anti-tobacco and anti-vaping organisations’ responses ranged from guarded acceptance to continued rejection on general health or more specifically youth enticement grounds.